Papillary Renal Cell Carcinoma Active Not Recruiting Phase 2 Trials for Pazopanib (DB06589)

IndicationStatusPhase
DBCOND0030667 (Papillary Renal Cell Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01767636Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney CancerTreatment